Skip to content

Clinical evaluation of the EDOF Vivity intraocular lens in patients after successful vitrectomy for rhegmatogenous retinal detachment (RRD) and concomitant cataract.

Clinical evaluation of the EDOF Vivity intraocular lens in patients after successful vitrectomy for rhegmatogenous retinal detachment (RRD) and concomitant cataract.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
DRKS
Registry ID
DRKS00037029
Enrollment
27
Registered
2025-05-27
Start date
2023-07-27
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H33.0 H25.1

Interventions

Group 1: Cataract surgery with the EDOF Vivity IOL

Sponsors

Augenklinik
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Stable and attached retina 3-6 months after vitrectomy. - BCVA between 0.3 and 0.7 LogMAR - The patient must sign a written declaration of consent before being included in the study. - For patients with successful retinal detachment surgery in both eyes, only the first eye will be considered for the primary endpoint. *The operation is defined as successful if functional and anatomical success can only be determined after an operation 3-6 months later

Exclusion criteria

Exclusion criteria: - High ammetropia (21 = AL = 28.5mm) - High corneal astigmatism (>3D) or other corneal pathology - Patients with macular involvement who were not treated within 3 days - Epiretinal macular membrane stage 3 and 4 (Govetto stage) - Glaucoma - Uveitis - History of retinal vascular occlusion - History of anti-VEGF therapy - Severe disintegration of the retinal layers (outer retinal layers) - Reduced retinal thickness compared to the fellow eye on OCT - History of ocular trauma.

Design outcomes

Primary

MeasureTime frame
Primary study outcome was monocular CDVA at 6 months after cataract surgery of primary eye.

Secondary

MeasureTime frame
Secondary outcomes included refractive outcome, CIVA, CNVA, UDVA, UIVA, UNVA, binocular UDVA, UIVA and UNVA. Explorative parameters included defocus curve, patient satisfaction, and halos/glare results.

Countries

Germany

Contacts

Public ContactArmin Wolf

Augenklinik

armin.wolf@uniklinik-ulm.de+4973150059001

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jul 27, 2026